The rising prevalence in GLP-1 medications for metabolic health has led to a debate about delivery routes : skin-applied devices versus tablets . Traditionally , GLP-1 treatments were exclusively https://miriamtorq960455.vblogetin.com/47059074/glp-1-transdermal-delivery-systems-vs-pills-is-best-for-the-patient